Figure 2
From: A novel model for predicting the prognosis of postoperative intrahepatic cholangiocarcinoma patients
Comparison of different hematological and clinical biomarkers in predicting the overall survival of intrahepatic cholangiocarcinoma patients. (A) The difference in the predictive ability of different hematological markers is shown in the time-dependent ROC curve, in which a larger AUC value indicates a better predictive ability. (B) Difference in the predictive ability of different clinical features. CA199, Carbohydrate antigen199; dNLR, derived neutrophil-to-lymphocyte ratio; LDH, lactate dehydrogenase; LMR, lymphocyte-monocyte ratio; AFP, α-fetoprotein; CEA, carcinoembryonic antigen; IIPI, intrahepatic immune prognostic index; HI, hilar invasion; MVI, microvascular invasion; TNM, Tumor Node Metastasis.
